Content area
Full Text
[Image omitted] - Taking activist investing up a notch
Name: Bill Ackman
Title: CEO, Pershing Square Capital Management
Last year, Bill Ackman brought activist investing to a whole new level when he teamed up with Valeant Pharmaceuticals ($VRX) on a hostile pursuit of Allergan ($AGN). And while the bid ultimately failed, it's hard to say the takeover fight won't be weighing on directors' minds this year.
For one, Ackman has already made a play for control at another industry player--animal health leader Zoetis ($ZTS). In...